The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
CHENGDU, China, May 30, 2026 /PRNewswire/ -- Sichuan Kelu...
XCMG Secures Over $1 Billion in Orders at 8th International Customer Festival, Expanding Global Partnerships
PRNewswire
Safe Power on Campus, Happy Growth for Kids - State Grid Minxian's Pre-Children's Day Initiative
PRNewswire
XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies
PRNewswire
Creality Marks 12 Years with KliTek™ and AI-Powered Ecosystem Expansion
PRNewswire
Contact Us
Notice
Back to Top
We use cookies to enhance your experience on our website. Please read and confirm your agreement to our Privacy Policy and Terms and Conditions before continue to browse our website. Read and Agreed